« Back to Record
Citation APA

Mingrone, G., van Baar, A. A., Devière, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., Costamagna, G., Haidry, R. R., Grecco, E., Galvao Neto, M. M., Aithal, G. P., Repici, A., Hayee, B., Haji, A., Morris, A. J., Bisschops, R., Chouhan, M. M., Sakai, N. N., Bhatt, D. D., Sanyal, A. J., & Bergman, J. J. (2021). Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut., gutjnl-2020-323608. doi:10.1136/gutjnl-2020-323608


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/320333

Mingrone, G., van Baar, A. A., Devière, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., Costamagna, G., Haidry, R. R., Grecco, E., Galvao Neto, M. M., Aithal, G. P., Repici, A., Hayee, B., Haji, A., Morris, A. J., Bisschops, R., Chouhan, M. M., Sakai, N. N., Bhatt, D. D., Sanyal, A. J., & Bergman, J. J. (2021). Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut., gutjnl-2020-323608. doi:10.1136/gutjnl-2020-323608